Cover image

Oncomedicine is an international journal publishing cutting edge research in oncology and medicine including basic sciences, pre-clinical and clinical studies. The journal aims to promote novel concepts, new methods, new regimens, new therapeutic agents and medicine, and innovative or alternative approaches for the detection, intervention and treatment of human malignancies and relevant diseases.

Types of articles:

  • Review and mini-review
  • Promising clinical trial outcome
  • Novel therapeutic regimen and protocol
  • Novel hypothesis, device, method, and biomarker
  • Commentary and letter to editor
  • Research and short research communication
  • Scientific debate on controversial issues
  • Special issues addressing urgent medical problems

Reviews or mini-reviews from leading scientists that give timely updates on all fields of oncology and medicine are particularly welcome and will be published in high priority and speed.

Latest articles:

Research Paper
COX-2 Inhibitors, a Potential Synergistic Effect with Antineoplastic Drugs in Lung Cancer
Wolfgang Hohenforst-Schmidt, Kalliopi Domvri, Nikolaos Zogas, Paul Zarogoulidis, Savvas Petanidis, Efrosini Kioseoglou, George Zachariadis, Stylianos Kakolyris, Konstantinos Porpodis, Mina Gaga, Haidong Huang, Theodor Kontakiotis, Konstantinos Zarogoulidis
Oncomedicine 2017; 2: 28-36. doi:10.7150/oncm.17020
[Abstract] [Full text] [PDF]

Research Paper
Antiemetic Effects of Granisetron or Metoclopramide Administered Prior to Amrubicin Monotherapy
Takeshi Aoyama, Kenichi Suzuki, Takashi Tsunoda, Kazuyoshi Kawakami, Tomomi Takiguchi, Hiroshi Watanabe, Wataru Suzuki, Kazuo Sugita, Hitoshi Sato, Erika Sugiyama, Toshihiro Hama, Makoto Nishio
Oncomedicine 2017; 2: 24-27. doi:10.7150/oncm.17486
[Abstract] [Full text] [PDF]

Review
Epidemiology, risk factors, symptomatology, TNM classification of Non Small Cell Lung Cancer. An overview while waiting the 8th TNM classification
Konstantinos Grapatsas, Vasilis Leivaditis, Zoi Tsilogianni, Eugene Haussmann, Vasili Kaplunov, Michael Dahm, Paul Zarogoulidis, Wolfgang Hohenforst-Schmidt, Kosmas Tsakiridis, Cristoforos Foroulis, Dimitrios Paliouras, Nikolaos Barbetakis, Basili Kosan
Oncomedicine 2017; 2: 14-23. doi:10.7150/oncm.17097
[Abstract] [Full text] [PDF]

Research Paper
Engineering Remotely Triggered Liposomes to Target Triple Negative Breast Cancer
Alexandra Sneider, Rahul Jadia, Brandon Piel, Derek VanDyke, Christopher Tsiros, Prakash Rai
Oncomedicine 2017; 2: 1-13. doi:10.7150/oncm.17406
[Abstract] [Full text] [PDF]

Review
A Focus on Current Molecular Pathways in Head and Neck
Ilias Karapantzos, Paul Zarogoulidis, Michail Karanikas, Vasilis Thomaidis, Charalampos Charalampidis, Chrysa Karapantzou
Oncomedicine 2016; 1: 28-34. doi:10.7150/oncm.16930
[Abstract] [Full text] [PDF]

Short Research Paper
ERCC1 Biomarker in Colorectal Cancer: To Induce or Not to Induce? This Is the Matter!
Mariantonietta Di Salvatore, Armando Orlandi, Carmela Paolillo, Francesca Aroldi, Mariagrazia Rodriquenz, Ettore Capolongo, Carlo Barone
Oncomedicine 2016; 1: 25-27. doi:10.7150/oncm.16256
[Abstract] [Full text] [PDF]

Review
Head and Neck Cancer Therapy from Bench to Bedside
Ilias Karapantzos, Paul Zarogoulidis, Michail Karanikas, Vasilis Thomaidis, Charalampos Charalampidis, Chrysa Karapantzou
Oncomedicine 2016; 1: 18-24. doi:10.7150/oncm.16928
[Abstract] [Full text] [PDF]

Short Research Paper
Cathelicidin LL-37 Promotes or Inhibits Cancer Cell Stemness Depending on the Tumor Origin
Guilherme Tude Coelho Neto, Thais Martins de Lima, Hermes Vieira Barbeiro, Roger Chammas, Marcel Cerqueira César Machado, Fabiano Pinheiro da Silva
Oncomedicine 2016; 1: 14-17. doi:10.7150/oncm.16802
[Abstract] [Full text] [PDF]

Review
Small Cell Lung Cancer: Current and Future Strategies
Sofia Lampaki, Paul Zarogoulidis, Kalliopi Lagoudi, Drosos Tsavlis, Ioannis Kioumis, Elena Papakala, George Lazaridis, Haidong Huang, Wolfgang Hohenforst-Schmidt, Pavlos Pavlidis, Kaid Darwiche, Nikolaos Barbetakis, Ilias Karapantzos, Chrysa Karapantzou, Aggeliki Rapti, Vasilis Karavasilis, Konstantinos Zarogoulidis
Oncomedicine 2016; 1: 4-13. doi:10.7150/oncm.16926
[Abstract] [Full text] [PDF]

Mini-review
γ-Synuclein as a Cancer Biomarker: Viewpoint and New Approaches
Andrei Surguchov
Oncomedicine 2016; 1: 1-3. doi:10.7150/oncm.16748
[Abstract] [Full text] [PDF]

Congratulations to our sister journal Journal of Cancer that obtains an Impact factor of 3.609 according to the 2016 release of Journal Citation Reports!